Boston Scientific Reports Positive Farapulse PFA System Data
Boston Scientific announced encouraging 12-month results from the ADVANTAGE AF trial for its Farapulse pulsed field ablation (PFA) system. The study, which involved 255 patients,
Boston Scientific announced encouraging 12-month results from the ADVANTAGE AF trial for its Farapulse pulsed field ablation (PFA) system. The study, which involved 255 patients,
CorWave has completed a successful preclinical in vivo study of its implantable heart pump, a left ventricular assist device (LVAD) utilizing innovative wave membrane technology.
Anumana has expanded its diagnostic ECG-AI technology into perioperative and acute cardiac care, bolstered by a new investment from Boston Scientific. The funding, part of
Medtronic has submitted 510(k) applications to the FDA for its interoperable insulin pump, marking a key milestone in its collaboration with Abbott. The submission aims
Onward Medical has announced the establishment of a Level 1 American Depositary Receipt (ADR) program to enhance its accessibility for U.S. investors. The ADRs, which
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
